GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 678 filers reported holding GLAXOSMITHKLINE PLC in Q4 2013. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $866,000 | -0.5% | 20,078 | 0.0% | 0.05% | -2.1% |
| Q2 2016 | $870,000 | -4.9% | 20,078 | -11.1% | 0.05% | -2.1% |
| Q1 2016 | $915,000 | +0.4% | 22,577 | 0.0% | 0.05% | -9.4% |
| Q4 2015 | $911,000 | -7.5% | 22,577 | -11.9% | 0.05% | -14.5% |
| Q3 2015 | $985,000 | -7.7% | 25,629 | 0.0% | 0.06% | +8.8% |
| Q2 2015 | $1,067,000 | +2.4% | 25,629 | +13.5% | 0.06% | +1.8% |
| Q1 2015 | $1,042,000 | +8.0% | 22,582 | 0.0% | 0.06% | +7.7% |
| Q4 2014 | $965,000 | -7.0% | 22,582 | 0.0% | 0.05% | -10.3% |
| Q3 2014 | $1,038,000 | +2.9% | 22,582 | +19.6% | 0.06% | +3.6% |
| Q2 2014 | $1,009,000 | +0.1% | 18,874 | 0.0% | 0.06% | -3.4% |
| Q1 2014 | $1,008,000 | 0.0% | 18,874 | 0.0% | 0.06% | +11.5% |
| Q4 2013 | $1,008,000 | +16.4% | 18,874 | +9.3% | 0.05% | +6.1% |
| Q3 2013 | $866,000 | +9.5% | 17,271 | +9.1% | 0.05% | +2.1% |
| Q2 2013 | $791,000 | – | 15,831 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chubb Ltd | 400,000 | $15,404,000 | 6.76% |
| KAHN BROTHERS GROUP INC | 833,315 | $32,090,960,000 | 5.42% |
| Sio Capital Management, LLC | 180,811 | $6,963,000 | 4.06% |
| Sio Capital Management, LLC | 170,000 | $6,547,000 | 3.82% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 1,124,462 | $43,304,000 | 3.12% |
| Keystone Financial Planning, Inc. | 120,705 | $4,648,000 | 3.04% |
| PVG Asset Management | 186,553 | $7,184,156,000 | 3.02% |
| P.R. Herzig & Co. Inc. | 37,950 | $1,461,000 | 2.98% |
| EQUITY INVESTMENT CORP | 2,329,469 | $89,708,000 | 2.89% |
| Sterneck Capital Management, LLC | 114,816 | $4,422,000 | 2.84% |